Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy

被引：0
|
作者：
Cruz Castellanos, P. [1 ]
Rosas Alonso, R. [1 ]
Ozaez, I. [1 ]
Hernandez, I. [1 ]
Losantos, I. [1 ]
Gutierrez Sainz, L. [1 ]
Higuera Gomez, O. [1 ]
Rodriguez Antolin, C. [1 ]
Esteban Rodriguez, I. [1 ]
Ibanez de Caceres, I. [1 ]
de Castro Carpeno, J. [1 ]
机构：
[1] Hosp Univ La Paz, IdiPAZ, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Non-small cell lung cancer; Next-Generation Sequencing (NGS); Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP16.01-00
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [21] MET Amplification in Non-Small Cell Lung Cancer (NSCLC)-A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting
    Schubart, Christoph
    Stoehr, Robert
    Toegel, Lars
    Fuchs, Florian
    Sirbu, Horia
    Seitz, Gerhard
    Seggewiss-Bernhardt, Ruth
    Leistner, Rumo
    Sterlacci, William
    Vieth, Michael
    Seidl, Christoph
    Mugler, Michael
    Kapp, Markus
    Hohenforst-Schmidt, Wolfgang
    Hartmann, Arndt
    Haller, Florian
    Erber, Ramona
    CANCERS, 2021, 13 (19)
  • [22] Quantitative t cell receptor (tcr) repertoire analysis by next-generation sequencing (ngs) in non-small cell lung cancer patients treated with therapeutic cancer peptide vaccines
    Fang, Hua
    Yamaguchi, Rui
    Liu, Xiao
    Daigo, Yataro
    Miyano, Satoru
    Nakamura, Yusuke
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Implementation of clinical next-generation sequencing (NGS) of non-small cell lung cancer (NSCLC) to identify EGFR amplification as a potentially targetable oncogenic alteration
    Oxnard, Geoffrey R.
    Lydon, Christine A.
    Lindeman, Neal Ian
    Shivdasani, Priyanka R.
    Chin, Gary Y.
    Kuo, Frank C.
    Johnson, Bruce E.
    Janne, Pasi A.
    Sholl, Lynette M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] A cell-free RNA-based next-generation sequencing (NGS) assay for the detection of actionable gene fusions in patients with non-small cell lung cancer (NSCLC)
    Choudhury, Yukti
    Cher, Chae Yin
    Ho, Jia Min
    Chan, Claire
    Teh, Mun Wei
    Ngeow, Kao Chin
    Pek, Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non-Small Cell Lung Cancer
    Yu, Tiffany M.
    Morrison, Carl
    Gold, Edward J.
    Tradonsky, Alison
    Arnold, Renee J. G.
    VALUE IN HEALTH, 2018, 21 (11) : 1278 - 1285
  • [26] Identification of next-generation EGFR degraders to treat non-small cell lung cancer (NSCLC) patients
    Ki, Dong Hyuk
    Nam, Joonwoo
    Kim, Eunjung
    Choi, Hunmi
    Kim, Chulwon
    Kim, Jiyeon
    Jin, Jimmy
    Kang, Sang-Uk
    Han, Wooseok
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Non-Small Cell Lung Cancer (NSCLC) Next Generation Sequencing (NGS): Integrating Genomic Sequencing into a Publicly Funded Health Care Model
    Perdrizet, K.
    Stockley, T.
    Law, J.
    Shabir, M.
    Zhang, T.
    Le, L.
    Lau, A.
    Tsao, M.
    Kamel-Reid, S.
    Pal, P.
    Cabanero, M.
    Schwock, J.
    Ko, H.
    Liu, G.
    Bradbury, P.
    Sacher, A.
    Shepherd, F.
    Leighl, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S367 - S368
  • [28] Therapeutic strategy for non-small cell lung cancer in the next-generation sequencing era
    Hayashi, Ryuji
    RESPIRATORY INVESTIGATION, 2021, 59 (01) : 1 - 2
  • [29] Clinical applications of a next-generation sequencing panel in non-small cell lung cancer
    Rijavec, E.
    Genova, C.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Dal Bello, M. G.
    Truini, A.
    Coco, S.
    Vanni, I.
    Alama, A.
    Grossi, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 86 - 87
  • [30] Genetic Profiling of Non-Small Cell Lung Cancer in Moroccan Patients by Targeted Next-Generation Sequencing
    El Zaitouni, Sara
    Laraqui, Abdelilah
    Ghaouti, Meriem
    Benzekri, Asmae
    Kettani, Fouad
    Boustany, Youssra
    Benmokhtar, Soukaina
    Alaoui, Hafsa Lamrani
    El Annaz, Hicham
    Abi, Rachid
    Tagajdid, Mohamed Rida
    El Kochri, Safae
    El Mchichi, Bouchra
    Bouaiti, El Arbi
    Lahlou, Idriss Amine
    El Hassani, Rabii Ameziane
    Ennibi, Khalid
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
12345